Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Simbrinza 10mg/ml / 2mg/ml eye drops
1106000ALBBAAAA
|
Simbrinza | Brinzolamide/brimonidine | Eye | 26,899 |
|
Equasym XL 30mg capsules
0404000M0BCAFAV
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | 26,785 |
|
Symbicort 200microg/dose / 6microg/dose pressurised inh
0302000K0BDADBB
|
Symbicort | Budesonide | Respiratory System | 26,738 |
|
GlucoRx CarePoint hypod insulin needles for pre-filled / reusable pen injectors screw on 6mm/31gauge
21010900700
|
GlucoRx CarePoint hypod insulin needles for pre-filled / reusable pen injectors screw on 6mm/31gauge | Other Appliances | Appliances | 26,635 |
|
Lamotrigine 25mg dispersible tablets sugar free
0408010H0AAAQAQ
|
Lamotrigine | Lamotrigine | Central Nervous System | 26,628 |
|
Fexofenadine 30mg tablets
0304010E0AAACAC
|
Fexofenadine hydrochloride | Fexofenadine hydrochloride | Respiratory System | 26,614 |
|
Dorzolamide 20mg/ml / Timolol 5mg/ml eye dps preserv free
1106000ABAAACAC
|
Dorzolamide and timolol | Dorzolamide and timolol | Eye | 26,606 |
|
Aptamil Pepti 1 powder
0913101A0BDAAAC
|
Aptamil Pepti 1 powder extensively hydrolysed formula | Powder extensively hydrolysed formula (0913101) | Nutrition and Blood | 26,600 |
|
Delofine XL 5mg tablets
0206020F0BNAAAB
|
Delofine | Felodipine | Cardiovascular System | 26,578 |
|
Qvar 100micrograms/dose Easi-Breathe inhaler
0302000C0BJAFBH
|
Qvar | Beclometasone dipropionate | Respiratory System | 26,573 |
|
StoCare Remove medical adhesive remover spray
23153931500
|
StoCare Remove medical adhesive remover spray | Adhesive Removers (Sprays/Liquids/Wipes) | Stoma Appliances | 26,533 |
|
Midodrine 5mg tablets
0207020Y0AAAFAF
|
Midodrine hydrochloride | Midodrine hydrochloride | Cardiovascular System | 26,529 |
|
Cefalexin 500mg tablets
0501021L0AAAHAH
|
Cefalexin | Cefalexin | Infections | 26,522 |
|
Benzoyl peroxide 5% gel
1306010C0AAABAB
|
Benzoyl peroxide | Benzoyl peroxide | Skin | 26,521 |
|
Sennosides 7.5mg/5ml oral solution sugar free
0106020V0AAABAB
|
Sennosides | Sennosides | Gastro-Intestinal System | 26,508 |
|
Insupen Original hypodermic insulin needles for pf / reusable pen injectors screw on 4mm/32 gauge
21012600105
|
Insupen Original hypodermic insulin needles for pf / reusable pen injectors screw on 4mm/32 gauge | Other Appliances | Appliances | 26,488 |
|
Tresiba FlexTouch 200units/ml inj 3ml pre-filled pens
0601012Z0BBACAC
|
Insulin Tresiba | Insulin degludec | Endocrine System | 26,446 |
|
Simpla Profile drainable night drainage bag with 120cm tube 2 litre
22601006045
|
Simpla Profile drainable night drainage bag with 120cm tube 2 litre | Night Drainage Bags | Incontinence Appliances | 26,444 |
|
GlucoRx HCT Glucose testing strips
0601060D0CUACA0
|
GlucoRx (Reagent) (Blood) | Glucose blood testing reagents | Endocrine System | 26,357 |
|
Colecalciferol 400unit tablets
0906040G0AAELEL
|
Colecalciferol | Colecalciferol | Nutrition and Blood | 26,356 |
|
Bunov 5micrograms/hour transdermal patches
0407020B0BUAAAH
|
Bunov | Buprenorphine | Central Nervous System | 26,324 |
|
Pyridostigmine bromide 60mg tablets
1002010Q0AAABAB
|
Pyridostigmine bromide | Pyridostigmine bromide | Musculoskeletal and Joint Diseases | 26,302 |
|
Elantan LA25 capsules
0206010K0BBAEAH
|
Elantan | Isosorbide mononitrate | Cardiovascular System | 26,273 |
|
Quetiapine 50mg modified-release tablets
0402010ABAAAVAV
|
Quetiapine | Quetiapine | Central Nervous System | 26,196 |
|
Epilim 200mg/5ml liquid
0408010W0BBADAA
|
Epilim | Sodium valproate | Central Nervous System | 26,082 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.